Calcium

GLP-1 drugs can cause weight loss, which results in an estimated 25% decline in musculoskeletal mass and increases the risk of fractures, especially for older adults. To mitigate this risk, patients should pair GLP-1 use with exercise and strength training while maintaining proper nutrition high in protein, calcium, vitamin D, and magnesium.

America faces a growing bone health crisis as aging populations experience increased fragility due to sedentary lifestyles, insufficient calcium/vitamin D intake, and a shortage of specialists. Over 50% of U.S. adults over 50 have low bone density or osteoporosis, leading to severe fractures and independence loss, with the U.S. potentially facing a $19 billion healthcare burden by 2038.

Andhra Pradesh has introduced a millet 'chikki' made from peanuts, blended millets, and jaggery syrup in government schools to enhance student nutrition. The snack is richer in dietary fiber and calcium and will be served three times a week.

Osteopenia is a common condition causing bones to become less dense and fragile, often discovered after a fracture or bone scan. Contributing factors include aging, menopause, poor diet, and inactivity, while solutions involve exercise, adequate calcium, vitamin D, and healthy habits.

Ozempic and Wegovy, GLP-1 receptor agonists, have been linked to significant muscle and bone loss in patients. Experts now outline strategies to mitigate these effects, including dietary adjustments, strength training, and monitoring calcium/vitamin D levels.

A recent study published in the BMJ found that Calcium and Vitamin D supplements do not prevent painful bone fractures and falls. Millions of people take these supplements to improve their bone health. The findings suggest that the benefits of these supplements may be overstated.